Filing metadata

Accession number
0001415889-21-005465
Form type
Form 4
Filer
Theravance Biopharma, Inc.
CIK
CIK 1583107
Filed
Nov 23, 2021
Reporting period
Nov 19, 2021
Description
Insider transaction

Explore SEC Filings Hub